X

Drug Profile

Alamifovir

Alternative Names: LY-582563; MCC-478

Latest Information Update: 24 Mar 2009

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Mitsubishi Pharma Corporation
Class Antivirals; Purine nucleotides; Small molecules
Mechanism of Action

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Discontinued Hepatitis B

Most Recent Events

01 Mar 2005 A study has been added to the Viral infections therapeutic trials section
12 Nov 2002 A preclinical study has been added to the Viral Infections antimicrobial activity section
24 Apr 2002 An animal study has been added to the Viral Infections pharmacodynamics section

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com